Global autism severity
Showing 1 - 25 of >10,000
Autism Spectrum Disorder Trial in Clayton (NTI164)
Not yet recruiting
- Autism Spectrum Disorder
-
Clayton, Victoria, AustraliaMonash Children's Hospital
Nov 22, 2022
Microbiome and Metabolome Profiling
Not yet recruiting
- Autism Spectrum Disorder
- no intervention
-
Cairo, EgyptAin shams University Hospitals (Unit of Phoniatrics-Otorhinolary
May 5, 2023
Nutritional Status and ASD Severity of Autistic Spectrum
Completed
- Autistic Spectrum Disorder
- Nutritional status
- +5 more
-
Addis Ababa, EthiopiaAddis Ababa Science and Technology University
Aug 23, 2022
Simplified Severity Score in Bullous Pemphigoid
Not yet recruiting
- Bullous Pemphigoid
- IGA score
- BULLOUS PEMPHIGOID DISEASE AREA INDEX (BPDAI)
-
Bordeaux, France
- +10 more
May 4, 2022
Autism Spectrum Disorder, Functional Gastrointestinal Disorders, Neurodevelopmental Disorders Trial in Brisbane (Synbiotic,
Active, not recruiting
- Autism Spectrum Disorder
- +3 more
- Synbiotic
- Gut-directed Hypnotherapy
-
Brisbane, Queensland, AustraliaUniversity of Queensland, Child Health Research Centre, Faculty
May 17, 2022
Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita Trial in London (IMP Application KM-001, Physical Examination,
Recruiting
- Punctate Palmoplantar Keratoderma Type 1
- Pachyonychia Congenita
- IMP Application KM-001
- +14 more
-
London, Whitechapel Rd, United KingdomRoyal London Hospital-Clinical Research Facility-11D (11th Floor
Jul 23, 2023
CCISO for Diagnosis of Autism Spectrum Disorder
Completed
- Autism Spectrum Disorder
- +2 more
- Do not take any interventions
-
Shanghai, Shanghai, ChinaChildren's hospital of Fudan University
Mar 30, 2022
Autism Spectrum Disorder Trial in Bron (ESDM-12, control group)
Completed
- Autism Spectrum Disorder
- ESDM-12
- control group
-
Bron, Aura, FranceHopital Vinatier
Jul 8, 2021
Autism Spectrum Disorder, Mental Retardation Trial in Montpellier (ADS severity, Adaptative and intellectual functioning,
Active, not recruiting
- Autism Spectrum Disorder
- Mental Retardation
- ADS severity
- +2 more
-
Montpellier, FranceCHU Montpellier
Dec 27, 2021
Brain Developmental Diseases, Autism Spectrum Disorder, Global Developmental Delay Trial in Shanghai (The early integrated
Completed
- Brain Developmental Diseases
- +3 more
- The early integrated intervention for GDD
- +5 more
-
Shanghai, Shanghai, ChinaChildren's hospital of Fudan University
Jan 6, 2022
Migraine Trial in Brisbane (Palmitoylethanolamide sold as Levagen +, Placebo comparator - maltodextrin and microcrystalline
Recruiting
- Migraine
- Palmitoylethanolamide sold as Levagen +
- Placebo comparator - maltodextrin and microcrystalline cellulose mix
-
Brisbane, Queensland, AustraliaRDC Global Pty Ltd
Dec 2, 2021
Autism Trial in Piscataway (Aripiprazole, Placebos)
Completed
- Autism
- Aripiprazole
- Placebos
-
Piscataway, New JerseyDepartment of Child and Adolescent Psychiatry, University Behavi
Dec 16, 2021
Translation and Validation of the COMM and ASI-SR
Not yet recruiting
- Opioid Use
- +3 more
- Current Opioid Misuse Measure (COMM)-SWE
- +11 more
- (no location specified)
Oct 16, 2023
Deep Brain Stimulation Trial in Shanghai (deep brain stimulation)
Recruiting
- Deep Brain Stimulation
- deep brain stimulation
-
Shanghai, ChinaShanghai Mental Health Center
Nov 6, 2023
Autism Spectrum Disorder Trial (Electromagnetic therapy)
Not yet recruiting
- Autism Spectrum Disorder
- Electromagnetic therapy
- (no location specified)
Oct 13, 2023
Autism Spectrum Disorder Trial in Chicago (Glutathione)
Enrolling by invitation
- Autism Spectrum Disorder
-
Chicago, IllinoisThe University of Chicago Medicine
Jul 12, 2023
Autism Spectrum Disorder Trial in Durham (hCT-MSC infusion)
Completed
- Autism Spectrum Disorder
- hCT-MSC infusion
-
Durham, North CarolinaDuke University Medical Center
Jan 19, 2023
Autism Trial in Columbia (Propranolol, Placebo)
Recruiting
- Autism
- Propranolol
- Placebo
-
Columbia, MissouriThompson Center for Autism & Neurodevelopmental Disorders
May 16, 2022
Autism Trial in Piscataway (Placebo, Docosahexanoic Acid)
Active, not recruiting
- Autism
- Placebo
- Docosahexanoic Acid
-
Piscataway, New JerseyRutgers
Oct 25, 2022
Autism Spectrum Disorder Trial (Cognilum TM: Light Treatment Condition)
Not yet recruiting
- Autism Spectrum Disorder
- Cognilum TM: Light Treatment Condition
- (no location specified)
Aug 17, 2023
Autism Spectrum Disorder Trial in Las Vegas (Low Dose ARD-501, High Dose ARD-501, Placebo)
Not yet recruiting
- Autism Spectrum Disorder
- Low Dose ARD-501
- +2 more
-
Las Vegas, NevadaCenter for Psychiatry and Behavioral Medicine Inc
Nov 9, 2023